Email Page
2018 FDLI Annual Conference
May 3, 2018

On May 3, Axinn partner Chad Landmon spoke at the Food and Drug Law Institute's Annual Conference in Washington, DC. The conference provided a forum to discuss the most current advances and forthcoming topics of interest in FDA law. Chad's presentation specifically focused on developments regarding biosimilars.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.